Concepedia
Statistics
Publications
10
Citations
285
H-Index
Active since
2004
Affiliations
Medical College of Wisconsin(Current)
The University of Texas MD Anderson Cancer Center
Rhizen Pharmaceuticals (Switzerland)
University of Colorado Denver
Case Western Reserve University
Kasi V. Routhu is an author at Medical College of Wisconsin specializing in vascular biology, medicine, and oxidative stress.
Top concepts
MedicineCardiologyPhysiologyPharmacologyOxidative StressVascular BiologyCardiovascular Disease
Publications per year
2004–2023
Protease-Activated Receptor 1 Inhibition by SCH79797 Attenuates Left Ventricular Remodeling and Profibrotic Activities of Cardiac Fibroblasts
Tetsuro Wakatsuki, Kasi V. Routhu, Leanne Harmann et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 2013 · 63 citations · Full text
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
Auris Huen, Bradley M. Haverkos, Jasmine M. Zain et al. · Cancers · 2020 · 62 citations · Full text
Cardioprotective activity of Hydrocotyle asiatica L. in ischemia-reperfusion induced myocardial infarction in rats
Rajeswara Rao Pragada, Krishna Kumar Veeravalli, K. P. R. Chowdary et al. · Journal of Ethnopharmacology · 2004 · 46 citations
Cardiovascular Disease, Reperfusion Injury, Medicine +9
Parstatin(1-26): The Putative Signal Peptide of Protease-Activated Receptor 1 Confers Potent Protection from Myocardial Ischemia-Reperfusion Injury
Kasi V. Routhu, Nikos E. Tsopanoglou, Jennifer L. Strande · Journal of Pharmacology and Experimental Therapeutics · 2009 · 22 citations
Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury
Jennifer L. Strande, Michael E. Widlansky, N. E. Tsopanoglou et al. · Cardiovascular Research · 2009 · 22 citations · Full text
1–5 of 10